Epigenetics in hyperhomocysteinemic states. A special focus on uremia
- 1 September 2009
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1790 (9) , 892-899
- https://doi.org/10.1016/j.bbagen.2008.11.010
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 2008
- Intra-individual Change Over Time in DNA Methylation With Familial ClusteringJAMA, 2008
- Somatically acquired hypomethylation of IGF2 in breast and colorectal cancerHuman Molecular Genetics, 2008
- Effect of Folic Acid and B Vitamins on Risk of Cardiovascular Events and Total Mortality Among Women at High Risk for Cardiovascular DiseaseJAMA, 2008
- Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J miceThe FASEB Journal, 2008
- Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin AgeneBlood, 2007
- The imprinted H19 noncoding RNA is a primary microRNA precursorRNA, 2007
- S‐Adenosylhomocysteine hydrolase deficiency in a 26‐year‐old manJournal of Inherited Metabolic Disease, 2006
- Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patientsKidney International, 2000
- Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine.Journal of Clinical Investigation, 1993